← back to search

Salvatore Albani

Duke-NUS Medical School · US
Area of research
Immunology · Hematology
Research interest
Research interests include Autoimmune and Inflammatory Disorders Research, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and Immune Cell Function and Interaction.
h-index
53
citations
11,035
works
227
NIH funding
primary concept
Medicine
email

Recent publications

A high dimensionality approach reveals immunopathogenic responses driving severe pediatric acute respiratory distress syndrome.
2026cited by 0position: contributordoi
Multi-omics and functional analysis of a bioengineered vascularized pancreatic cancer model reveal an immunosuppressive and therapy-resistant niche
2026cited by 0position: contributordoi
Epigenetic instability and hypofunctionality of fetal Tregs allow a permissive regulatory environment for T effector memory maturation.
2025cited by 1position: contributordoi
Genetic interrogation for sequence and copy number variants in systemic lupus erythematosus.
2024cited by 3position: contributordoi
iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer
Nature 2023cited by 195position: middledoi
iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer.
2023cited by 151position: contributordoi
The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity
International Journal of Molecular Sciences 2023cited by 60position: middledoi
The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.
2023cited by 36position: contributordoi
IFNγ<sup>-</sup>IL-17<sup>+</sup> CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.
2023cited by 31position: contributordoi
Compartmentalization and persistence of dominant (regulatory) T cell clones indicates antigen skewing in juvenile idiopathic arthritis.
2023cited by 10position: contributordoi
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosus.
2023cited by 7position: contributordoi
COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases.
2023cited by 3position: contributordoi
Juvenile idiopathic arthritis.
2022cited by 191position: contributordoi
Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC
Hepatology 2022cited by 156position: middledoi
Hypoxia-driven immunosuppression by Treg and type-2 conventional dendritic cells in HCC.
2022cited by 132position: contributordoi
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
Journal of Hepatology 2022cited by 120position: middledoi
Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling.
2022cited by 111position: contributordoi
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
Journal of Hepatology 2022cited by 105position: contributordoi
Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
Nature Communications 2022cited by 58position: middledoi
Trajectory of immune evasion and cancer progression in hepatocellular carcinoma.
2022cited by 48position: contributordoi
IFNγ−IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma
Cancer Letters 2022cited by 36position: middledoi
Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure.
2022cited by 16position: contributordoi
Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort.
2022cited by 16position: contributordoi
A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma.
2022cited by 15position: contributordoi
Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases.
2022cited by 14position: contributordoi
Toward Molecular Stratification and Precision Medicine in Systemic Sclerosis.
2022cited by 5position: contributordoi
Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease
Immunity 2021cited by 636position: middledoi
Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease.
2021cited by 527position: contributordoi
Microbial exposure during early human development primes fetal immune cells
Cell 2021cited by 312position: middledoi
Microbial exposure during early human development primes fetal immune cells.
2021cited by 205position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 11 papers (2020–2026)Pierce K. H. Chow · SingHealth9 papers (2017–2022)Charles-Antoine Dutertre · Institut National des Sciences Appliquées Rouen Normandie7 papers (2019–2025)Florent Ginhoux · Institut Gustave Roussy7 papers (2020–2025)Thaschawee Arkachaisri · VNU University of Science6 papers (2020–2023) · 6 papers (2020–2022) · 6 papers (2020–2026)Jerry Kok Yen Chan · NGM Biopharmaceuticals (United States)5 papers (2021–2025) · 5 papers (2020–2026)Wai Leong Tam · Disco (Germany)5 papers (2020–2022)Stuart A. Cook · University of Otago4 papers (2019–2021)Jing Yao Leong · SingHealth4 papers (2014–2021)Joe Poh Sheng Yeong · Bioinformatics Institute4 papers (2019–2022) · 4 papers (2020–2022)Camillus Chua · SingHealth4 papers (2014–2018)Marco Gattorno · Istituto Giannina Gaslini3 papers (2016–2020)Jessie Tan · National University of Singapore3 papers (2019–2021) · 3 papers (2020–2022)Jinmiao Chen · Guangzhou Medical University3 papers (2020–2026)Joo Guan Yeo · Taipei Medical University3 papers (2020–2022)